Statins Safe, Effective in Rheumatoid Arthritis Patients
FRIDAY, April 19, 2019 -- Daily atorvastatin is safe for the primary prevention of cardiovascular events (CVE) in patients with rheumatoid arthritis, conferring a similar degree of risk reduction in these patients as in other populations, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2019 Category: Pharmaceuticals Source Type: news

4 Medtech Innovations That Are Tearing up the Script
Decision Resources Group (DRG) released a new report today, "4 Crazy Medtech Innovations" that identifies four areas of medtech innovation that are forecasted to shake up the treatment landscape within the next five years. "The reason we decided to look at crazy innovation in medtech was that a few people on our consulting team were doing that and to help them out we decided to do a scan talking to our different data experts, therapy experts, [to learn] what have people seen that's actually crazy innovation," Lexie Code, director of medtech learning at DRG, told MD+DI. After gathering intel from each of...
Source: MDDI - April 18, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Non-invasive vagus nerve stimulation shows promise for treatment of rheumatoid arthritis
(Northwell Health) Bioelectronic medicine scientists at The Feinstein Institute for Medical Research collaborated with counterparts from Academic Medical Center at University of Amsterdam in the Netherlands to carry out a series of pilot clinical studies to assess the effect of a novel bioelectronic stimulation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 16, 2019 Category: International Medicine & Public Health Source Type: news

Statins safe for rheumatoid arthritis patients
Patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits as other individuals Related items fromOnMedica Lifestyle intervention in type 2 diabetes can have long-term effect Heart disease and stroke deaths plummet in Scotland Brexit could result in thousands of extra CVD deaths CHD and stroke risk seriously elevated with just one daily cigarette Obesity associated with worse mortality and higher CVD risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 16, 2019 Category: UK Health Source Type: news

Statins Safe, May Reduce CV Events in RA Statins Safe, May Reduce CV Events in RA
Statins are safe and likely effective for preventing cardiovascular events among patients with rheumatoid arthritis, but not every patient with RA needs the drug, new data suggest.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 15, 2019 Category: Cardiology Tags: Rheumatology News Source Type: news

Statins safe for preventing cardiovascular events in rheumatoid arthritis patients
(Wiley) Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks. The findings appear in Arthritis& Rheumatology, an official journal of the American College of Rheumatology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 15, 2019 Category: International Medicine & Public Health Source Type: news

Getting closer: Finding out why the immune system attacks itself
(University of Houston) University of Houston biomolecular engineer Navin Varadarajan thinks B cells gone bad could be the culprit in Rheumatoid Arthritis and he is the first to publish a comprehensive profile of the cells, moving closer to finding out why the immune system attacks itself in patients with RA. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 11, 2019 Category: International Medicine & Public Health Source Type: news

Rheumatoid arthritis warning - do your hands feel like this? Hidden tingling symptoms
RHEUMATOID arthritis symptoms include joint pain, inflammation and restricted movement. But the condition, which affects around 400,000 people in the UK, could also cause a hidden tingling symptom. Are your hands affected by this sign? (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2019 Category: Consumer Health News Source Type: news

Predicting Flare Risk After Stopping Adalimumab in RA Predicting Flare Risk After Stopping Adalimumab in RA
A new study examines the question of whether adalimumab trough and antidrug antibody levels predict flare among rheumatoid arthritis patients who have stopped adalimumab.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2019 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Why Does Medicine Cost So Much? Here ’s How Drug Prices Are Set
From 2007 to 2016, Mylan raised the list price of its EpiPen about 500%, from just under $100 to more than $600. From 2002 to 2013, insulin prices more than tripled. From 2012 to 2019, the average price of AbbVie’s rheumatoid-arthritis drug Humira climbed from $19,000 a year to $60,000 a year—and that’s after rebates. These are dramatic examples of a systemwide problem: prices for brand-name drugs are rising at a rate that far outstrips inflation. What’s behind these rapid price hikes? It’s a simple question with a complicated answer that involves three central entities: drug manufacturers, ph...
Source: TIME: Health - April 9, 2019 Category: Consumer Health News Authors: Laura Entis Tags: Uncategorized medicine Source Type: news

France Bans Textured Breast Implants
France has banned several types of textured breast implants that have been linked to a rare form of cancer, and more countries appear to be following suit, including Canada and the Netherlands. For years researchers have raised concern about the potential association between breast implants and anaplastic large cell lymphoma (ALCL), a very rare form of cancer, but France is the first country to ban the devices. The ban took effect on Friday and covers macro-textured implants and implants with a polyurethane coating. The National Agency for Safety of Medicines and Health Products (ANSM) in France notified manufa...
Source: MDDI - April 8, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Regulatory and Compliance Source Type: news

Housecall: Living with rheumatoid arthritis
THIS WEEK'S TOP STORIES Tips for coping with rheumatoid arthritis? If you have rheumatoid arthritis, the best thing you can do is follow your health care provider's advice and take medications exactly as prescribed. You also can take steps at home to manage your pain and stay active. Learn more from Dr. April Chang-Miller, a [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 8, 2019 Category: Databases & Libraries Source Type: news

Acupuncture reduces the risk of coronary heart disease in people with rheumatoid arthritis
(Natural News) One of the most widely used methods for relieving pain is acupuncture. It is especially recommended to people with rheumatoid arthritis – a chronic autoimmune disease that causes inflammation, swelling and pain in the joints and other body organs. Because of its scope, people suffering from RA have a high risk of developing other... (Source: NaturalNews.com)
Source: NaturalNews.com - April 7, 2019 Category: Consumer Health News Source Type: news

Ask What Is Safest Drug for Rheumatoid Arthritis
What Is the Safest Drug for Rheumatoid Arthritis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 5, 2019 Category: General Medicine Source Type: news

Women Die From Heart Attacks More Often Than Men. Here ’s Why — and What Doctors Are Doing About It
Lilly Rocha was 37 years old in 2008 when she began having strange symptoms. When people asked her questions, she knew the answers but couldn’t articulate them. A tingling sensation on her left breast became painful. She thought she might have breast cancer, but her doctor assured her she was just experiencing stress from her demanding job. Her symptoms continued to get worse, and doctors continued to dismiss her. Three months later, at work, she became seriously ill. Luckily, her boss recognized the symptoms—chest and jaw pain and numbness in her left hand—and drove her to the nearest emergency room, whe...
Source: TIME: Health - April 1, 2019 Category: Consumer Health News Authors: Barbara Sadick Tags: Uncategorized heart health Source Type: news

Patients With Worse RA Symptoms More Likely to Cut Alcohol Intake
FRIDAY, March 29, 2019 -- Higher disease activity, disability, comorbidity, and poor quality of life contribute to reductions in alcohol use among patients with rheumatoid arthritis (RA), according to a study published online March 20 in Arthritis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 29, 2019 Category: Pharmaceuticals Source Type: news

Shares in Galapagos jump 15 percent after arthritis drug results
Shares in Belgian drugmaker Galapagos surged nearly 16 percent on Friday after the company said it had seen positive results from several safety and efficacy trials of its rheumatoid arthritis drug filgotinib. (Source: Reuters: Health)
Source: Reuters: Health - March 29, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Higher Disease Burden for OA Than RA After Six Months
WEDNESDAY, March 27, 2019 -- After six months, osteoarthritis (OA) is associated with higher mean disease burden than rheumatoid arthritis (RA), according to a study published online March 20 in Arthritis& Rheumatology. Jacquelin R. Chua, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 27, 2019 Category: Pharmaceuticals Source Type: news

Rheumatoid arthritis warning - the painful and itchy rash you should never ignore
RHEUMATOID arthritis symptoms include joint pain, inflammation and restricted movement. But the condition, which affects about 400,000 people in the UK, could also cause an itchy rash. Could your skin be affected by the painful sign? (Source: Daily Express - Health)
Source: Daily Express - Health - March 25, 2019 Category: Consumer Health News Source Type: news

FDA Busts J & amp;J and Sientra Over Breast Implant Compliance
FDA busted two manufacturers of silicone gel-filled breast implants this week for failure to comply with post-approval study requirements. The agency sent warning letters to Irvine, CA-based Mentor Worldwide, a unit of Johnson & Johnson, and to Santa Barbara, CA-based Sientra for deficiencies in each company's post-approval study for silicone breast implant approvals. Breast implants have been a source of contention between patient advocacy groups, industry, and FDA for decades. Implants were banned from the U.S. market from 1992 to 2006, and the devices have been the cause of an ove...
Source: MDDI - March 20, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

Disease burden in osteoarthritis is similar to rheumatoid arthritis
(Wiley) Osteoarthritis (OA) has traditionally been viewed as a highly prevalent but milder condition when compared with rheumatoid arthritis (RA), and some may believe that it is part of a normal aging process requiring acceptance, not treatment. A new study in Arthritis& Rheumatology indicates that OA and RA have similar impacts or burdens on patients when they first visit rheumatologists, however. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 20, 2019 Category: International Medicine & Public Health Source Type: news

Does alcohol consumption have an effect on arthritis?
(Wiley) Several previous studies have demonstrated that moderate alcohol consumption is linked with less severe disease and better quality of life in patients with rheumatoid arthritis, but a new Arthritis Care& Research study suggests that this might not be because drinking alcohol is beneficial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 20, 2019 Category: International Medicine & Public Health Source Type: news

Smoking May Not Inhibit Response to Rituximab in Rheumatoid Arthritis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - March 17, 2019 Category: Orthopaedics Tags: Perspective Source Type: news

Noninvasive ultrasound stimulation of spleen could lead to new treatments for inflammatory arthritis
(University of Minnesota) Researchers at the University of Minnesota, in collaboration with researchers at Medtronic, have shown that noninvasive daily ultrasound stimulation of the spleen in mice with inflammatory arthritis resulted in significantly less joint swelling compared to arthritic mice that were not treated. The research is a first step to developing new treatment options for more than a million people in the United States who currently suffer from rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2019 Category: International Medicine & Public Health Source Type: news

Abatecept Retention Longest When Used First-Line (CME/CE)
(MedPage Today) -- Also, starting abatacept sooner may improve efficacy in rheumatoid arthritis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 7, 2019 Category: Primary Care Source Type: news

Autoimmune rheumatic disease: Mayo Clinic Radio Health Minute
Rheumatoid arthritis, lupus and vasculitis are just a few examples of autoimmune rheumatic diseases. ?In this Mayo Clinic Radio Health Minute, Dr. Eric Matteson talks about the prevalence of these types of diseases and where treatment is headed. To listen, click the link below. Autoimmune rheumatic disease (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 6, 2019 Category: Databases & Libraries Source Type: news

Rheumatoid Arthritis Risk Lower Among Smokers Who Quit Rheumatoid Arthritis Risk Lower Among Smokers Who Quit
Adults who quit smoking decades ago may have a lower risk of rheumatoid arthritis than people who gave up cigarettes more recently, a U.S. study suggests.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - March 5, 2019 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Rheumatoid arthritis risk lower among smokers who quit
(Reuters Health) - Adults who quit smoking decades ago may have a lower risk of rheumatoid arthritis than people who gave up cigarettes more recently, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA: Pulmonary Embolism Risk Up With Tofacitinib 10 mg for RA
THURSDAY, Feb. 28, 2019 -- A safety clinical trial has revealed that tofacitinib (Xeljanz, Xeljanz XR) 10 mg twice daily is associated with an increased risk for pulmonary embolism (PE) and death among patients with rheumatoid arthritis (RA), the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2019 Category: Pharmaceuticals Source Type: news

Sustained Smoking Cessation May Delay, Prevent Seropositive RA
WEDNESDAY, Feb. 27, 2019 -- While smoking is a strong risk factor for seropositive rheumatoid arthritis (RA), sustained smoking cessation could delay or even prevent disease development, according to a study published online Feb. 21 in Arthritis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 27, 2019 Category: Pharmaceuticals Source Type: news

FDA warns of blood clots and death associated with higher dose of Pfizer's Xeljanz
A safety clinical trial found an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of the drug was used in patients with rheumatoid arthritis. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - February 26, 2019 Category: Pharmaceuticals Source Type: news

FDA Warns of Risk for PE, Death With Higher Dose Xeljanz FDA Warns of Risk for PE, Death With Higher Dose Xeljanz
The FDA is warning of an increased risk for pulmonary embolism and death in patients with rheumatoid arthritis who received tofacitinib (Xeljanz, Xeljanz XR) 10 mg twice daily in a postmarketing study.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 26, 2019 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Safety trial finds risk of blood clots in the lungs and death with higher dose of tofacitinib (Xeljanz, Xeljanz XR) in rheumatoid arthritis patients; FDA to investigate
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 25, 2019 Category: Drugs & Pharmacology Source Type: news

Abatacept Retention Higher Without Prior Biologics
(MedPage Today) -- Earlier use in rheumatoid arthritis may improve efficacy (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 25, 2019 Category: Primary Care Source Type: news

Surprise rheumatoid arthritis discovery points to new treatment
(University of Virginia Health System) Researchers have identified an unexpected contributor to rheumatoid arthritis that may help explain the painful flare-ups associated with the disease. The discovery points to a potential new treatment for the autoimmune disorder and may also allow the use of a simple blood test to detect people at elevated risk for developing the condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 22, 2019 Category: International Medicine & Public Health Source Type: news

Stop Smoking and Stop RA?
(MedPage Today) -- Risk for rheumatoid arthritis declined with many years'cessation, but some risk remained (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 21, 2019 Category: Primary Care Source Type: news

Rheumatoid Arthritis
Title: Rheumatoid ArthritisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/21/2019 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 21, 2019 Category: Rheumatology Source Type: news

Smoking cessation may reduce risk of rheumatoid arthritis
(Brigham and Women's Hospital) Analysis of data from the Nurses' Health Studies demonstrates for first time that behavior change can delay or even prevent the most severe form of rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 21, 2019 Category: International Medicine & Public Health Source Type: news

Smoking Cessation May Reduce Risk of Rheumatoid Arthritis
Analysis demonstrates for first time that behavior change can delay or prevent most severe form of rheumatoid arthritis (Source: BWH News)
Source: BWH News - February 21, 2019 Category: Hospital Management Source Type: news

Rheumatoid arthritis: Three vitamins and minerals to reduce arthritis pain and symptoms
RHEUMATOID arthritis is the second most common type of arthritis in the UK. The condition is incurable, but pain and symptoms can be reduced by including certain vitamins and minerals that are beneficial to joint health. Here are three to ensure you include in your diet if you have arthritis. (Source: Daily Express - Health)
Source: Daily Express - Health - February 20, 2019 Category: Consumer Health News Source Type: news

Quality of Life Poor in Scleroderma
(MedPage Today) -- Worse than in rheumatoid arthritis or lupus (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 20, 2019 Category: Primary Care Source Type: news

LabCorp expands drug monitoring portfolio
LabCorp Diagnostics (NYSE: LH), the Burlington-based lab testing giant, is expanding its therapeutic drug monitoring portfolio with a new investigative assessment to monitor a drug that treats inflammatory diseases such as rheumatoid arthritis and Crohn's disease. The DoseAssure CTZ assay is LabCorp's latest addition to its therapeutic drug monitoring menu. It will track a study that allows physicians to monitor patients on the drug Certolizumab. “Biologic drugs can be life-changing, but individual… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 19, 2019 Category: American Health Authors: Margaret Moffett Source Type: news

AbbVie Announces New Drug Application Accepted for Priority Review by U.S. FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
Upadacitinib, an investigational once-daily oral JAK1-selective inhibitor, is being studied for the treatment of adult patients with moderate to severe rheumatoid arthritis[1-8] The New Drug Application (NDA) is supported by data from the global upadaci... Biopharmaceuticals, FDA AbbVie, Upadacitinib, Rheumatoid Arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 19, 2019 Category: Pharmaceuticals Source Type: news

AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
NORTH CHICAGO, Ill., Feb. 19, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review its New Drug Application (NDA)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - February 19, 2019 Category: Drugs & Pharmacology Source Type: news

Is Remission Achievable in Most Patients With RA? Is Remission Achievable in Most Patients With RA?
This editorial explores the question of whether sustained remission in rheumatoid arthritis is achievable.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 18, 2019 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Cranberry juice may help to relieve pain for people suffering from rheumatoid arthritis
A study by researchers from the University of Londrina, Brazil, tracked 41 women with rheumatoid arthritis for 90 days. Those who drank cranberry juice reported fewer swollen joints. (Source: the Mail online | Health)
Source: the Mail online | Health - February 18, 2019 Category: Consumer Health News Source Type: news

Smoking and HLA Genes in Rheumatoid Arthritis
(MedPage Today) -- New study sorts out relative contributions of these risk factors (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 16, 2019 Category: Primary Care Source Type: news

Arthritis in pregnant women increases the child’s risk of epilepsy by 160 percent, according to study of over a million births
(Natural News) Children who are born to mothers who experienced rheumatoid arthritis during their pregnancy are more likely to have epilepsy. As published in the journal of Arthritis Care & Research, the study led by Dr. Line Jølving from the Odense University Hospital carried out a nationwide study of all children born during a 25-year... (Source: NaturalNews.com)
Source: NaturalNews.com - February 16, 2019 Category: Consumer Health News Source Type: news

Medical News Today: The best home remedies for arthritis
Many home remedies can help relieve arthritis symptoms, including yoga, massage, and omega-3 fatty acids. Learn more about these and other home remedies for arthritis here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 14, 2019 Category: Consumer Health News Tags: Rheumatoid Arthritis Source Type: news

Cochrane's 30 under 30: Shalini Suresh
Cochrane is made up of  13,000 members and over 50,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.Cochrane is an incredible community of people who all play their part in improving health and healthcare globally. We believe that by putting trusted evidence at the heart of health decisions we can achieve a world of improved health for all.  Many  of our contributors are young people working with Cochrane ...
Source: Cochrane News and Events - February 14, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news